B
8.81
0.13 (1.50%)
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | BridgeBio Oncology Therapeutics | Menaik | - |
AISkor Stockmoo
2.4
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 4.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 2.40 |
|
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Omega Fund Management, Llc | 31 Dec 2025 | 3,289,661 |
| Laurion Capital Management Lp | 31 Dec 2025 | 1,464,938 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 29.00 (HC Wainwright & Co., 229.17%) | Beli |
| Median | 24.00 (172.42%) | |
| Rendah | 23.00 (Stifel, 161.07%) | Beli |
| Purata | 25.33 (187.51%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 11.88 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 06 Mar 2026 | 29.00 (229.17%) | Beli | 10.42 |
| Stifel | 11 Feb 2026 | 23.00 (161.07%) | Beli | 12.04 |
| Raymond James | 09 Jan 2026 | 24.00 (172.42%) | Beli | 13.19 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2026 | Pengumuman | BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
| 07 Jan 2026 | Pengumuman | BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |